Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG
Karen L. Kotloff(University of Maryland, Baltimore), M. M. Levine(University of Maryland, Baltimore), Marcelo B. Sztein(University of Maryland, Baltimore), Steven S. Wasserman(University of Maryland, Baltimore), James P. Nataro(University of Maryland, Baltimore), G Losonsky, Fernando Noriega(Novavax (United States))
Cited by 110
Related Papers
Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet Infectious Diseases|2017|1.4k
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
|PubMed|1999|1.3k
Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
|New England Journal of Medicine|2014|941
Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study
|The Lancet|2019|923
Origins of the <i>E. coli</i> Strain Causing an Outbreak of Hemolytic–Uremic Syndrome in Germany
|New England Journal of Medicine|2011|833